original ) (raw )Predictors and Moderators of Antipsychotic-Related Weight Gain in the Treatment of Early-Onset Schizophrenia Spectrum Disorders Study
Michael Bloch
Journal of Child and Adolescent Psychopharmacology, 2018
View PDFchevron_right
The association between weight change and symptom reduction in the CATIE schizophrenia trial
jeffrey lieberman
Schizophrenia Research, 2011
View PDFchevron_right
Impact of Switching or Initiating Antipsychotic Treatment on Body Weight During a 6-Month Follow-Up in a Cohort of Patients With Schizophrenia
Denis Leguay
Journal of Clinical Psychopharmacology, 2012
View PDFchevron_right
Acute weight gain, gender, and therapeutic response to antipsychotics in the treatment of patients with schizophrenia
Bruce J Kinon
BMC psychiatry, 2005
View PDFchevron_right
A 6-month randomized controlled trial to test the efficacy of a lifestyle intervention for weight gain management in schizophrenia
Mário Mateus
BMC Psychiatry, 2013
View PDFchevron_right
Pharmacological Strategies to Counteract Antipsychotic-Induced Weight Gain and Metabolic Adverse Effects in Schizophrenia: A Systematic Review and Meta-analysis
Takefumi Suzuki
Schizophrenia Bulletin, 2014
View PDFchevron_right
Atypical Antipsychotic Induced Weight Gain in Schizophrenic Patients
tetie herlina
Indonesian Journal of Clinical Pharmacy, 2021
View PDFchevron_right
Weight Management Program for Treatment-Emergent Weight Gain in Olanzapine-Treated Patients With Schizophrenia or Schizoaffective Disorder
영준 신
The Journal of Clinical Psychiatry, 2006
View PDFchevron_right
Weight gain from novel antipsychotic drugs: need for action
R. Goisman
General Hospital Psychiatry, 2000
View PDFchevron_right
CoMET: a randomised controlled trial of co-commencement of metformin versus placebo as an adjunctive treatment to attenuate weight gain in patients with schizophrenia newly commenced on clozapine
Gail Robinson
Therapeutic Advances in Psychopharmacology, 2021
View PDFchevron_right
Predictors of Antipsychotic-Induced Weight Gain in First-Episode Psychosis
Sahoo Saddichha
Journal of Clinical Psychopharmacology, 2008
View PDFchevron_right
The Complex Relationship between Antipsychotic-Induced Weight Gain and Therapeutic Benefits: A Systematic Review and Implications for Treatment
Ilona Gorbovskaya
Frontiers in neuroscience, 2017
View PDFchevron_right
Long-term treatment of antipsychotics and combined therapy with other psychotropic medications inducing weight gain in patients with non-affective psychotic disorder: Evidence from GROUP, a longitudinal study
Claudia Simons
Psychiatry Research
View PDFchevron_right
Weight gain in newly diagnosed first-episode psychosis patients and healthy comparisons: One-year analysis
Martin Strassnig , J. Miewald
Schizophrenia Research, 2007
View PDFchevron_right
Weight gain and antipsychotics. Data from EUFEST study
Valentin Matei , Traian Purnichi
View PDFchevron_right
Schizophrenia and weight management: a systematic review of interventions to control weight
Andrew Soundy
Acta Psychiatrica Scandinavica, 2003
View PDFchevron_right
Pharmacological Add-On Treatments in Managing Antipsychotic-Induced Weight Gain
Codrina Moraru
The European Conference of Psychiatry and Mental Health "Galatia"
View PDFchevron_right
Effect of treatment on weight gain and metabolic abnormalities in patients with first-episode psychosis
Mythily Subramaniam
Australian and New Zealand Journal of Psychiatry, 2009
View PDFchevron_right
Course and predictors of weight gain in people with first-episode psychosis treated with olanzapine or haloperidol
Jeffrey Lieberman
The British Journal of Psychiatry, 2005
View PDFchevron_right
Weight gain over 4 months in schizophrenia patients: a comparison of olanzapine and risperidone
Rohan Ganguli
Schizophrenia Research, 2001
View PDFchevron_right
Antipsychotic-induced weight gain in first-episode psychosis patients: a meta-analysis of differential effects of antipsychotic medications
Aniyizhai Annamalai
Early Intervention in Psychiatry, 2015
View PDFchevron_right
The effect of zonisamide on antipsychotic-associated weight gain in patients with schizophrenia: A randomized, double-blind, placebo-controlled clinical trial
Mohammad Nikseresht
Schizophrenia Research, 2013
View PDFchevron_right
Effects of a 10‐week weight control program on obese patients with schizophrenia or schizoaffective disorder: A 12‐month follow up
Yu-shu Huang
Psychiatry and Clinical Neurosciences, 2009
View PDFchevron_right
Weight gain in patients with schizophrenia treated with risperidone, olanzapine, quetiapine or haloperidol: results of the EIRE study
Gabriela Hernandez
Schizophrenia Research, 2003
View PDFchevron_right
Weight gain, metabolic disturbances, and physical health care in a Brazilian sample of outpatients with schizophrenia
Mario Louzã
Neuropsychiatric Disease and Treatment, 2013
View PDFchevron_right
Association between antipsychotic medication and clinically relevant weight change: meta-analysis
Bea Campforts
View PDFchevron_right
Early evaluation of patient risk for substantial weight gain during olanzapine treatment for schizophrenia, schizophreniform, or schizoaffective disorder
I. Lipkovich
BMC Psychiatry, 2008
View PDFchevron_right
Twenty-Four Week, Randomized, Double-Blind, Placebo-Controlled Trial of Metformin for Antipsychotic-Induced Weight Gain in Patients with First-Episode Psychosis: A Pilot Study
Edimansyah abdin
International Journal of Environmental Research and Public Health, 2021
View PDFchevron_right
Weight gain management in patients with schizophrenia during treatment with olanzapine in association with nizatidine
João Campos
Revista Brasileira de Psiquiatria, 2006
View PDFchevron_right
Switching antipsychotics as a treatment strategy for antipsychotic-induced weight gain and dyslipidemia
Peter Weiden
The Journal of clinical psychiatry, 2007
View PDFchevron_right
The Association between Schizophrenia Clinical Severity and Obesity Risk: A Literature Review
Jack Hester
Journal of Student Research, 2021
View PDFchevron_right
Antipsychotic Medications and Weight Gain: Etiologies, Predictors and Adverse Clinical Consequences
Saud Alsanad
International Neuropsychiatric Disease Journal, 2018
View PDFchevron_right